Friday · Nov 13, 2026 · Health Digest · public-health
CDC: about 1 in 10 US adults used a GLP-1 drug in 2025, and 44% of users changed how they took it
The estimate is based on survey responses from more than 8,000 US adults collected in July and August 2025, Ars Technica reported. Users reported skipping doses, delaying refills and taking smaller doses than prescribed, among other changes.
The CDC report found 22.6% of users took a compounded GLP-1, which the FDA does not approve, and 8.8% did not know whether theirs was compounded. Among compounded-drug users, 62% were not taking them as prescribed, compared with 36% of brand-name users, Ars Technica reported.
Why it matters: The authors called for more research on the safety and quality of compounded GLP-1 drugs and on common dose and frequency changes.
References
- Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025CDC MMWR · cdc.gov · 2026-11-13
- Millions of Americans are not taking their GLP-1 drugs as prescribedArs Technica · arstechnica.com · 2026-11-13
- How Americans are really using GLP-1s, per the CDCBecker's Hospital Review · beckershospitalreview.com · 2026-11-13